These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34506563)

  • 1. A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C.
    Atsukawa M; Tsubota A; Kondo C; Uchida-Kobayashi S; Takaguchi K; Tsutsui A; Nozaki A; Chuma M; Hidaka I; Ishikawa T; Iwasa M; Tamai Y; Tobari M; Matsuura K; Nagura Y; Abe H; Kato K; Suzuki K; Okubo T; Arai T; Itokawa N; Toyoda H; Enomoto M; Tamori A; Tanaka Y; Kawada N; Takei Y; Iwakiri K
    PLoS One; 2021; 16(9):e0257166. PubMed ID: 34506563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B Patients.
    Jekarl DW; Choi H; Lee S; Kwon JH; Lee SW; Yu H; Kim M; Kim Y; Sung PS; Yoon SK
    Ann Lab Med; 2018 Jul; 38(4):348-354. PubMed ID: 29611385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outreach screening of drug users for cirrhosis with transient elastography.
    Moessner BK; Jørgensen TR; Skamling M; Vyberg M; Junker P; Pedersen C; Christensen PB
    Addiction; 2011 May; 106(5):970-6. PubMed ID: 21182552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.
    Ziol M; Handra-Luca A; Kettaneh A; Christidis C; Mal F; Kazemi F; de Lédinghen V; Marcellin P; Dhumeaux D; Trinchet JC; Beaugrand M
    Hepatology; 2005 Jan; 41(1):48-54. PubMed ID: 15690481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient Elastography (FibroScan) Performs Better Than Non-Invasive Markers in Assessing Liver Fibrosis and Cirrhosis in Autoimmune Hepatitis Patients.
    Guo L; Zheng L; Hu L; Zhou H; Yu L; Liang W
    Med Sci Monit; 2017 Oct; 23():5106-5112. PubMed ID: 29073121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study.
    Gomez-Moreno AZ; Pineda-Tenor D; Jimenez-Sousa MA; Sánchez-Ruano JJ; Artaza-Varasa T; Saura-Montalban J; Ryan P; Resino S
    PLoS One; 2017; 12(9):e0184404. PubMed ID: 28880930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
    Behairy Bel-S; Sira MM; Zalata KR; Salama el-SE; Abd-Allah MA
    World J Gastroenterol; 2016 Apr; 22(16):4238-49. PubMed ID: 27122674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].
    Chen GF; Ping J; Gu HT; Zhao ZM; Zhou Y; Xing F; Tao YY; Mu YP; Liu P; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):145-150. PubMed ID: 28297803
    [No Abstract]   [Full Text] [Related]  

  • 10. Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.
    Ogawa Y; Honda Y; Kessoku T; Tomeno W; Imajo K; Yoneda M; Kawanaka M; Kirikoshi H; Ono M; Taguri M; Saito S; Yamanaka T; Wada K; Nakajima A
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1795-1803. PubMed ID: 29633352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
    Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
    Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of FibroTouch combined with four hepatic fibrosis biomarkers for evaluation of the liver fibrosis degree among patients with chronic schistosomiasis-induced liver disorders].
    Hong Y; Niu XH; Shen YZ; Zhou L; Huang LP
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Jan; 33(6):629-633. PubMed ID: 35128895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis.
    Toshima T; Shirabe K; Ikegami T; Yoshizumi T; Kuno A; Togayachi A; Gotoh M; Narimatsu H; Korenaga M; Mizokami M; Nishie A; Aishima S; Maehara Y
    J Gastroenterol; 2015 Jan; 50(1):76-84. PubMed ID: 24603981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis.
    Petta S; Cammà C; DI Marco V; Calvaruso V; Enea M; Bronte F; Butera G; Cabibi D; Craxì A
    Aliment Pharmacol Ther; 2009 Sep; 30(6):603-13. PubMed ID: 19563503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.
    Posthouwer D; Mauser-Bunschoten EP; Fischer K; VAN Erpecum KJ; DE Knegt RJ
    J Thromb Haemost; 2007 Jan; 5(1):25-30. PubMed ID: 17239163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum WFA
    Zou X; Zhu MY; Yu DM; Li W; Zhang DH; Lu FJ; Gong QM; Liu F; Jiang JH; Zheng MH; Kuno A; Narimatsu H; Zhang Y; Zhang XX
    Liver Int; 2017 Jan; 37(1):35-44. PubMed ID: 27300763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.
    Chan HL; Wong GL; Choi PC; Chan AW; Chim AM; Yiu KK; Chan FK; Sung JJ; Wong VW
    J Viral Hepat; 2009 Jan; 16(1):36-44. PubMed ID: 18673426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of transient elastography by FibroScan for the evaluation of liver fibrosis.
    Sharma P; Dhawan S; Bansal R; Tyagi P; Bansal N; Singla V; Kumar A; Matin A; Arora A
    Indian J Gastroenterol; 2014 Sep; 33(5):445-51. PubMed ID: 25138787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
    Fujiyoshi M; Kuno A; Gotoh M; Fukai M; Yokoo H; Kamachi H; Kamiyama T; Korenaga M; Mizokami M; Narimatsu H; Taketomi A;
    J Gastroenterol; 2015 Nov; 50(11):1134-44. PubMed ID: 25773774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data.
    Hong WK; Kim MY; Baik SK; Shin SY; Kim JM; Kang YS; Lim YL; Kim YJ; Cho YZ; Hwang HW; Lee JH; Chae MH; Kim HA; Kang HW; Kwon SO
    Clin Mol Hepatol; 2013 Dec; 19(4):370-5. PubMed ID: 24459641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.